The invention relates to an anti HIV 1 vaccine comprising the entire or part of the Tat HIV 1 protein, in addition to the identification of said protein in individuals affected by HIV. The Tat protein is a protein of the HIV 1 Oyi variant.

 
Web www.patentalert.com

< Methods for determining plasma free drug concentration by direct measurement of binding affinity of protease inhibitors to plasma proteins

< Method for determining the mechanism of HIV RT inhibitors

> Composition and method for stimulating immune response to pathogen using complex adenoviral vector

> Methods and compositions for inhibiting HIV infectivity and blocking chemokine activity
~ 00281